InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of disease-modifying small molecule drug









